Scooter, you could very well be right; Fuse may have already been approached by some pharma company but was (are) not willing to sell-out because they know they hold an "ACE". Going it alone may be significantly better in the long term than selling all the goods in the near term... pure speculation on my part, true, but it definitely appears that Fuse is putting together the building blocks for a major global enterprise. Sure, time will tell. Hope good news comes promptly, not a year or two down the road.
Market Data 
Markets 
AI
